Patrick Verschueren
About
In The Last Decade
Patrick Verschueren
162 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 128
- Rheumatology 1.7k
- Hematology 480
- Immunology 434
- Pathology and Forensic Medicine 383
- Radiology, Nuclear Medicine and Imaging 337
Countries citing papers authored by Patrick Verschueren
This map shows the geographic impact of Patrick Verschueren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Verschueren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Verschueren more than expected).
Fields of papers citing papers by Patrick Verschueren
This network shows the impact of papers produced by Patrick Verschueren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Verschueren. The network helps show where Patrick Verschueren may publish in the future.
Co-authorship network of co-authors of Patrick Verschueren
This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Verschueren. A scholar is included among the top collaborators of Patrick Verschueren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Verschueren. Patrick Verschueren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 6 | |
| 6 | 0 | |
| 7 | 8 | |
| 8 | 56 | |
| 9 | 90 | |
| 10 | 80 | |
| 11 | 15 | |
| 12 | 1 | |
| 13 | Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts. | 4 |
| 14 | Anti-TNF treatment and renal cell carcinoma in patients with inflammatory bowel disease, rheumatoid arthritis and spondyloarthropathy: trigger or cure? | 1 |
| 15 | 44 | |
| 16 | Comparison of MTX Therapy with or without A Moderate Dose Glucocorticoid Bridging Scheme in Early Rheumatoid Arthritis Patients Lacking Classical Poor Prognostic Markers: Week 16 Results from the Randomized Multicenter Carera Trial | 2 |
| 17 | The phenotype and genotype of rheumatoid arthritis in the Democratic Republic of Congo | 1 |
| 18 | Predictors of remission, normalized function and changes in the working situation of patients with early RA | 1 |
| 19 | Activation of bone morphogenetic protein signalling in rheumatoid arthritis | 1 |
| 20 | Reduced cellularity and expression of adhesion molecules and cytokines after treatment with soluble human recombinant TNF receptor (P75) in RA patients | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.